Page 234 - Demo

Notes to the Consolidated Financial Statements31 December 2024232ADVANCING AHEAD41.SHARE-BASED COMPENSATION PLAN (continued)A.Share Option Plan by the Company (continued)The exercise prices and exercise periods of the share options outstanding as at the end of each of the years ended 31 December 2024 and 2023 are as follows:Number of options20242023Exercise priceExercise period%u2019000%u2019000per share7,8007,800US$0.460020-04-17to20-01-26%u2013100US$0.472201-01-23* to 22-02-297,7099,227US$0.944501-01-23* to 19-05-29873873US$1.145316-08-23* to 15-08-28948948US$1.365516-02-24* to 25-02-291,9882,260US$1.517220-05-24* to 19-05-296,1506,650HK$27.3028-12-21to27-12-3010,64211,194HK$24.5023-08-21 to 22-08-31384#384#HK$22.7808-06-22to07-06-3236,49439,436*Participants will have an unconditional right to exercise an option to the extent that it is vested after the earliest of the followings:a)an IPO;b)an Early Vesting Event;c)5 years of the date of grant.If there is (i) a sale of all or substantially all of the shares in; or (ii) a disposal of all or substantially all of the business of the member of the Group of which a participant is a director or by which the participant is employed, as appropriate, by way of trade sale or by way of sale to a third party (an %u201cEarly Vesting Event%u201d), any options granted to the participant will vest in full on the occurrence of the Early Vesting Event.#%u0009 Totalshareoptionsof384,000,atanexercisepriceofHK$22.78,weregrantedtothedirectorsofCompany,JinchuShenandStuartGibson on 8 June 2022, in equal amount. The share options vest in three equal tranches on 8 June 2022, 8 June 2023 and 8 June 2024.The1,507,531shareoptionsexercisedduringtheyearresultedintheissueof489,599ordinarysharesoftheCompany and new share capital of US$490 (before issue expenses), as further detailed in note 40.At 31 December 2024, the Company had 36,493,698 share options outstanding under the Plans. The exercise in full of the outstanding share options by the conventional exercise method would, under the present capital structure of the Company, result in the issue of 36,493,698 additional ordinary shares of the Company and additionalsharecapitalandsharepremiumofUS$72,425(beforeissueexpenses).At the date of approval of these financial statements, the Company had 36,493,698 share options outstanding under the Plans, which represented approximately 0.86% of the Company%u2019s shares in issue as at that date.